Get the Stockscreener App
1.65
1.20%
-0.02
After Hours:
1.65
Mira Pharmaceuticals Inc stock is traded at $1.65, with a volume of 245.08K.
It is down -1.20% in the last 24 hours and up +36.36% over the past month.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
See More
Previous Close:
$1.67
Open:
$1.67
24h Volume:
245.08K
Relative Volume:
0.19
Market Cap:
$27.92M
Revenue:
-
Net Income/Loss:
$-11.24M
P/E Ratio:
-2.1668
EPS:
-0.7615
Net Cash Flow:
$-4.79M
1W Performance:
-5.17%
1M Performance:
+36.36%
6M Performance:
+37.50%
1Y Performance:
-21.43%
1-Day Range:
$1.6266
$1.7113
1-Week Range:
$1.60
$1.79
52-Week Range:
$0.73
$2.7899
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals Inc
Sector
Industry
Phone
813-369-5150
Address
1200 BRICKELL AVENUE, MIAMI
Compare MIRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.65 | 30.85M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
740.07 | 682.35B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
164.74 | 402.82B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
189.02 | 334.40B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
113.74 | 225.78B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
78.12 | 205.28B | 63.62B | 16.41B | 17.04B | 6.49 |
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
What catalysts could drive MIRA Pharmaceuticals Inc. stock higher in 2025Post Market Target Finder To Watch Now - jammulinksnews.com
How does MIRA Pharmaceuticals Inc. generate profit in a changing economyReal Time Planner For Fast Growth - jammulinksnews.com
What are the technical indicators suggesting about MIRA Pharmaceuticals Inc.Daily Trading Outlook With Proven Results - jammulinksnews.com
How many analysts rate MIRA Pharmaceuticals Inc. as a “Buy”Best Dividend Report From AI Tools - jammulinksnews.com
Key External Factors That Drive MIRA Pharmaceuticals Inc. Stock Price MovementsStep-by-Step Stock Investment Guide Gains Popularity - metal.it
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - The Daily Corinthian
Revolutionary Topical Pain Drug Rivals Morphine in Efficacy: Major Breakthrough in $11.5B Market - Stock Titan
MIRA Pharmaceuticals Reports Promising Preclinical Results - TipRanks
Is This a Bottoming Phase for MIRA Pharmaceuticals Inc.Stock Market Entry Timing Signals Revealed - metal.it
FDA clears MIRA’s IND application for neuropathic pain drug Ketamir-2 - Investing.com Nigeria
FDA clears MIRA’s IND application for neuropathic pain drug Ketamir-2 By Investing.com - Investing.com South Africa
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain - Corsicana Daily Sun
MIRA's Novel Pain Drug Shows 112% Better Relief Than Current Treatments, FDA Gives Green Light - Stock Titan
Does MIRA Pharmaceuticals Inc. stock perform well during market downturnsSmart Portfolio Recommendation For Beginners - jammulinksnews.com
MIRA Pharmaceuticals Gets FDA Clearance for Ketamir-2 Trials - TipRanks
What makes MIRA Pharmaceuticals Inc. stock price move sharplyExpert Picks Alerts For Beginners - jammulinksnews.com
How does MIRA Pharmaceuticals Inc. compare to its industry peersDiscover stocks with superior performance - jammulinksnews.com
How hedge fund analytics apply to MIRA Pharmaceuticals Inc. stockReal Time Screener for Growth Trades - Newser
Is MIRA Pharmaceuticals Inc. stock overvalued or undervaluedFree Predictions - jammulinksnews.com
What are the latest earnings results for MIRA Pharmaceuticals Inc.Discover hidden gems in the stock market - jammulinksnews.com
What is the risk reward ratio of investing in MIRA Pharmaceuticals Inc. stockExtraordinary profit generation - jammulinksnews.com
Is MIRA Pharmaceuticals Inc. Stock a Good Fit for Conservative InvestorsSafe and Scalable Investment Tips - Newser
Is it the right time to buy MIRA Pharmaceuticals Inc. stockCapitalize on fast-moving market trends - jammulinksnews.com
Why Baijiayun Group Ltd stock attracts strong analyst attentionExpert Trading Flow - Newser
Is MIRA Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Swing Trade Signals - Newser
MIRA Pharmaceuticals Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - PrintWeekIndia
Is MIRA Pharmaceuticals Inc. a good long term investmentBreakthrough profit margins - PrintWeekIndia
What drives MIRA Pharmaceuticals Inc. stock priceSuperior risk-adjusted returns - PrintWeekIndia
Is MIRA Pharmaceuticals Inc. stock a good hedge against inflationAccelerated earnings growth - jammulinksnews.com
What analysts say about MIRA Pharmaceuticals Inc. stockHigh-return market picks - PrintWeekIndia
Can Liberty Latin America Ltd. stock recover from recent declineSuperior returns - jammulinksnews.com
FCEL Stock Analysis and ForecastRapid market gains - jammulinksnews.com
Mira Pharmaceuticals Inc Stock (MIRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):